The Fiscal Year 2013 (FY13) Defense Appropriation Act provides for $15 million to the Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP) to research cancers not addressed in breast, prostate, lung (excluding mesothelioma), and ovarian cancer research programs currently executed by the DoD U.S. Army Medical Research and Materiel Command (USAMRMC).
Congressionally Directed Topic Areas: To be considered for funding, applications for the FY13 PRCRP must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted. The FY13 PRCRP Topic Areas are listed below:
• Blood cancers
• Colorectal cancer
• Genetic cancer research
• Kidney cancer
• Listeria vaccine for cancer
• Melanoma and other skin cancers
• Mesothelioma
• Neuroblastoma
• Pancreatic cancer
• Pediatric brain tumors
New for FY13 – Military Relevance Focus Areas:
Susceptibility to developing cancers due to exposure to militarily relevant environmental or chemical carcinogens (including transgenerational effects)
Identification of predictive and prognostic biomarkers of developing cancers due to exposure to militarily relevant environmental or chemical carcinogens
Molecular mechanisms by which environmental influences associated with military exposures alter gene structure, stability, and expression
Examination of cancer diagnosis and prognosis effects on the psychosocial well-being of military beneficiaries
The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY13 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2013. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
Career Development Award
Eligibility
Principal Investigator: Independent investigator at the level of Assistant Professor, Instructor, or equivalent within 7 years of first faculty appointment (or equivalent) at the time of application deadline
Designated Collaborator: Investigators at or above the level of Associate Professor (or equivalent); must have a proven publication and funding record in at least one of the FY13 PRCRP Topic Areas. May not have a major research focus on breast, prostate, lung (excluding mesothelioma), or ovarian cancer
Key Mechanism Elements
Supports early-career investigators to conduct innovative research in collaboration with an experienced cancer researcher
Must address at least one of the FY13 PRCRP Topic Areas
Strongly encouraged to address at least one of the FY13 PRCRP Military Relevance Focus Areas
Must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research
Optional Nested Postdoctoral Fellow Traineeship
Preliminary data not required
Clinical trials not allowed
Funding
Maximum funding for the entire period of performance is $240,000 in direct costs (plus indirect costs)
If requesting the Optional Nested Postdoctoral Fellow Traineeship, the maximum funding for the entire period of performance is $360,000 in direct costs (plus indirect costs).
Maximum period of performance is 2 years
Idea Award with Special Focus
Eligibility
Independent investigator at or above the level of Assistant Professor (or equivalent)
Key Mechanism Elements
Supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are directly relevant to service members, their families, and other military beneficiaries
Emphasis on innovation and military relevance/impact
Must address at least one of the FY13 PRCRP Topic Areas
Must address at least one of the FY13 PRCRP Military Relevance Focus Areas
Must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research
Preliminary data discouraged
Clinical trials not allowed
Funding
Maximum funding for the entire period of performance is $300,000 in direct costs (plus indirect costs)
Maximum period of performance is 2 years
All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be made available on the Grants.gov website. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.
For more information about the PRCRP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs, 301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil
No comments:
Post a Comment